NPR series examines global progress against AIDS

NewsGuard 100/100 Score

In a special series called "AIDS: A Turning Point," NPR reports on global progress against HIV/AIDS ahead of the AIDS 2012 conference taking place in Washington, D.C., this month. As part of the series, NPR's "Morning Edition" examines Botswana's response to the epidemic, writing, "A decade ago, Botswana was facing a national crisis as AIDS appeared on the verge of decimating the country's adult population. Now, Botswana provides free, life-saving AIDS drugs to almost all of its citizens who need them." According to the show, "Part of the reason Botswana's HIV treatment program has been effective is that the country moved relatively quickly to address the epidemic" and "over the course of the epidemic, Botswana has steadily increased its own spending on HIV" (7/9).

In a separate "Morning Edition" story, NPR examines HIV among men who have sex with men (MSM) in Kenya, writing, "Nationwide, roughly six percent of adults in Kenya are infected with HIV. But the rate among [MSM] is more than three times the national average." The news service notes, "Health officials in Kenya say reducing the transmission of HIV among [MSM] is a central part of their national AIDS strategy," but "they face serious challenges, including the fact that homosexuality is still a crime in the East African nation." NPR adds, "The stigma toward homosexuality creates a broader health problem, as [MSM] maintain heterosexual relationships to fit in in society" (Beaubien, 7/9).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Breakthrough study offers hope for an effective HIV cure